Introduction

Based in Edinburgh, Scotland, 1nhaler Ltd was founded by Don Smith and Lisa McMyn in 2017. They have assembled a team of industry experts with decades of experience taking inhaled products to market.

Our device has the potential to become the simplest, most convenient single-dose, disposable inhaler on the market, revolutionising the delivery of critical drugs, without the cost and environmental impact of existing devices.

Leadership team

  • Lisa McMyn

    Chief Executive Officer

    Experienced business executive, product development expert and serial entrepreneur. Co-founded 1nhaler Ltd with Don Smith in 2017.

  • Don Smith

    Chief Innovation Officer

    Award-winning Creative Director for nearly 20 years, Don is now focused on his 1nhaler invention. Co-founded 1nhaler Ltd with Lisa McMyn in 2017.

  • Helen Muirhead

    Chief Scientific Officer

    Arguably the world’s most experienced respiratory DDC expert after 30 years at GSK where she was responsible for Diskus and Ellipta Portfolio.

  • Khadija Schwach

    Business Development Director

    Scientist turned BD Executive, Formerly Global Head M&A and BD at PM Lifesciences leading the acquisition of inhalation companies Vectura and Otitopic.

  • Gordon Muirhead

    Expert Advisor

    Formerly VP Global Manufacturing and Supply for GSK, responsible for delivery of new prescription medicines: respiratory and oral dose forms and devices.

  • Joanne Kelley

    Board Director

    Formerly Vice President of Business Development, Head of Transactions at AstraZeneca. Director of Alderley Park Ventures and a consultant for pharma companies.

Contact us.

We are actively seeking partnerships, so please get in touch if you’d like to discuss our technology.